Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|January 19, 2020
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centersThomas Hueso, Thomas Gastinne, Sylvain Garciaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or OlderLucie Oberic, Frederic Peyrade, Mathieu Puyade, et al.
British Journal of Haematology|November 13, 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational studyLaurent Garderet, Hafida Ouldjeriouat, Mohamed-Amine Bekadja, et al.
American Journal of Hematology|June 10, 2018
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centersCédric Rossi, Julia Gilhodes, Marie Maerevoet, et al.
Blood|January 25, 2020
High total metabolic tumor volume at baseline predicts survival independent of response to therapyLaetitia Vercellino, Anne-Segolene Cottereau, Olivier Casasnovas, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohortAmélie Anota, Mathurine Basset, Emilie Charton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2022
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS StudyCaroline Houillier, Sylvain Dureau, Luc Taillandier, et al.
Blood Advances|August 20, 2024
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapyVincent Camus, Roch Houot, Gabriel Brisou, et al.
Nature Medicine|September 22, 2022
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphomaEmmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, et al.
Blood Advances|October 22, 2025
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registryFederico Erbella, Emmannuel Bachy, Guillaume Cartron, et al.
Pageof 6